Imunon Inc (IMNN) FinancialsIMNNImunon Inc

Evaluating the bottom line, Imunon Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -641.03%, provide a clear picture of how effectively IMNN converts its operational activities into shareholder value.

In the context of the broader market, IMNN competes directly with industry leaders such as SNTI and LGVN. With a market capitalization of $21.80M, it holds a leading position in the sector. When comparing efficiency, IMNN's gross margin of N/A stands against SNTI's 100.00% and LGVN's 63.41%. Such benchmarking helps identify whether Imunon Inc is trading at a premium or discount relative to its financial performance.

Imunon has reported consistent net income losses, with a net loss of $2.8 million in Q2 2026 and a gross profit of $0.00 in Q4 2024, indicating ongoing financial struggles.